🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although sorafenib is effective and safe in patients with advanced hepatoce...
Status
Completed
Location
301 Military Hospital, Beijing, China
Start Date
2009-07
Trial ID
NCT01934829
Treatments Being Tested
This study will examine the efficacy of topical amethocaine gel (Ametop) in...
Status
Completed
Location
Mount Sinai Hospital
Start Date
2003-07
Trial ID
NCT00267111
Treatments Being Tested
The objective of this study is to assess the effect of 'Eucerin AtopiContro...
Status
Completed
Location
Fraunhofer ITEM
Start Date
2017-10-02
Trial ID
NCT03315611
Treatments Being Tested
Acne is an inflammation of sebaceous glands and follicles. Applying topical...
Status
Completed
Location
Siriraj Hospital Mahidol Univeristy
Start Date
2014-07
Trial ID
NCT02173054
Treatments Being Tested
The main objective of the study is to assess the efficacy of an antioxidant...
Status
Completed
Location
Innovaderm Research Inc
Start Date
2013-08
Trial ID
NCT01927679
While the repair of the epidermal barrier in atopic dermatitis is of major ...
Status
Completed
Location
DermResearch, PLLC
Start Date
2010-02
Trial ID
NCT01065714
Treatments Being Tested
Dry skin is a physiological condition and is characterized in contrast to g...
Status
Completed
Location
Department of Dermatology, University of Münster
Start Date
2008-04
Trial ID
NCT00669708
Treatments Being Tested
This is a single site, randomized, open-label comparison pilot study to ass...
Status
Completed
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2020-07-27
Trial ID
NCT04173247
Treatments Being Tested
This study is a prospective, randomized controlled, double blinded, study i...
Status
Completed
Location
Hospital Network Antwerp
Start Date
2010-01
Trial ID
NCT01213420
Topical metronidazole is a widely used first line treatment for erythemotel...
Status
Completed
Location
Duke University Medical Center
Start Date
2024-09-03
Trial ID
NCT06434519